Uncategorized

Executives at companies innovating a range of new robotic surgery platforms shared their progress and challenges in MedTech Dive’s series of profiles.

Stanley Bergman has worked at Henry Schein for 45 years, more than 35 of which he spent as CEO, and was due to retire at the end of 2025.

The expanded tax credits are officially dead after lawmakers failed to secure an extension before the end-of-year deadline. There’s still a chance, though a small one, that they could come back in 2026.

The fierce rivalry between Novo Nordisk and Eli Lilly is alive and well, as the two companies are expected to face off with their new obesity pills this year.

After getting the crucial first-mover advantage with an FDA approval for a weight loss pill, Novo looks to win the market before rival Lilly can arrive with its own oral option for obesity.

The Illinois-based pharma has committed more than $1 billion in milestones to secure rights to ZG006 and join a who’s who of drugmakers targeting the DLL3 protein.

J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action could improve on existing therapies.

Según las Naciones Unidas, aproximadamente una de cada once personas en todo el mundo pasó hambre en 2023, y más de tres mil millones no pudieron costearse una alimentación saludable. Por lo tanto, se deben desarrollar métodos de producción de alimentos m&aa …

Unos científicos han descubierto que el SARS-CoV-2, el virus causante de la COVID-19, utiliza una táctica sofisticada para evadir el sistema de defensa del cuerpo humano. Además de la capacidad, común a otros virus, de burlar el sistema inmunitario antes de invadir la c&e …

Cuando el hielo se derrite pasando a ser agua, el paso de sólido a líquido en el punto afectado ocurre rápidamente. Sin embargo, esto no sucede así en los materiales bidimensionales (láminas con un grosor del orden del átomo). En vez de eso, aparece un estad …